 CARLSBAD, Calif., Feb. 10, 2022 GLOBE NEWSWIRE -- Design Therapeutics, Inc. Nasdaq: DSGN, a biotechnology company developing treatments for degenerative genetic disorders, today reported that João Siffert, M.D., president and chief executive officer, and Sean Jeffries, Ph.D., chief operating officer, will participate in a fireside chat during the SVB Leerink 11th Annual Global Healthcare Conference on Thursday, February 17, 2022 at 11:20 a.m. ET. 